本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

30.39
+1.093.72%
盘前30.760.3700+1.22%04:11 EST
成交量:198.93万
成交额:5,872.54万
市值:28.03亿
市盈率:-106.13
高:30.44
开:29.48
低:27.47
收:29.30
52周最高:42.13
52周最低:12.91
股本:9,224.16万
流通股本:9,122.00万
量比:1.06
换手率:2.18%
股息:- -
股息率:- -
每股收益(TTM):-0.2864
每股收益(LYR):-0.2864
净资产收益率:-57.80%
总资产收益率:-6.55%
市净率:24.41
市盈率(LYR):-106.13

数据加载中...

2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities